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ABSTRACT Three series of 22-residue peptides derived from the transmembrane M2 segment of the glycine receptor
a1-subunit (M2GlyR) have been designed, synthesized, and tested to determine the plasticity of a channel-forming sequence
and to deﬁne whether channel pores with enhanced conductive properties could be created. Sixteen sequences were examined
for aqueous solubility, solution-association tendency, secondary structure, and half-maximal concentration for supramolecular
assembly, channel activity, and ion transport properties across epithelial monolayers. All peptides interact strongly with membranes:
associating with, inserting across, and assembling to form homooligomeric bundles when in micromolar concentrations. Single and
double amino acid replacements involving arginine and/or aromatic amino acids within the ﬁnal ﬁve C-terminal residues of the
peptide cause dramatic effects on the concentration dependence, yielding a range of K1/2 values from 36 6 5 to 390 6 220 mM for
transport activity. New water/lipid interfacial boundaries were established for the transmembrane segment using charged or
aromatic amino acids, thus limiting the peptides’ ability to move perpendicularly to the plane of the bilayer. Formation of discrete
water/lipid interfacial boundaries appears to be necessary for efﬁcient supramolecular assembly and high anion transport activity. A
peptide sequence is identiﬁed that may show efﬁcacy in channel replacement therapy for channelopathies such as cystic ﬁbrosis.
INTRODUCTION
A variety of ionophores and channels are available to
dissipate electrical and/or chemical gradients across cell
membranes for therapeutic, industrial, and research pur-
poses. For example, valinomycin is widely employed as a
K1 selective ionophore to dissipate chemical gradients
across cell membranes, monensin has been used to selec-
tively dissipate Na1 gradients, and A23187 has been used in
protocols to increase cytosolic Ca21. Unfortunately, there
are no commercially available anion-selective ionophores or
channels that can be topically applied from purely aqueous
solutions. The development of chloride selective pores would
ﬁnd applied use in the clinic for treating channelopathies
such as cystic ﬁbrosis, and in basic research by producing
anionophores that modulate counterion movement when
studying cation channels. In a recent review on artiﬁcial
channels for Na1 and K1, it was observed (1) that peptide-
based channel designs achieved high unitary conductance
but low selectivity whereas chemically synthesized ion-
speciﬁc macrocycles show high selectivity but low transport
rates. Native protein channels can simultaneously exhibit
relatively high conductance and anion/cation selectivity.
These observations suggest that studies need to be conducted
to explore whether or not these deﬁciencies in the synthetic
channels can be overcome.
In our laboratory we have approached the issue of
understanding chloride selectivity in a biological setting by
focusing on sequence variants of the 23 amino acid, second
transmembrane segment (TM2) of the a1-subunit of the
spinal cord glycine receptor (M2GlyR, PARVGLGITTVL
TMTTQSSGSRA) (2,3). Over 200 sequences have been
chemically synthesized and analyzed for increased aqueous
solubility, decreased solution associations, and reduced
concentrations for supramolecular assembly rates. Early
sequences adducted varying numbers of lysine residues on
one of the peptide termini (4). The highly soluble CK4-
M2GlyR-p27 (PARVGLGITTVLTMTTQSSGSRAKKKK)
and NK4-M2GlyR- p27 (KKKKPARVGLGITTVLTMTTQ
SSGSRA) peptides displayed preferred ion transport activ-
ities, as evidenced by their ability to permit anion secretion
(measured as short-circuit current, Isc across conﬂuent
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epithelial monolayers) and pharmacological responses that
were similar to those seen with the parent M2GlyR sequence
(2,3). However the NK4- sequence displayed higher trans-
port activity even though it formed higher molecular weight
aggregates relative to the CK4- peptide (5,6). NMR studies
revealed that the lysines in the CK4- peptide formed a
capping structure that led to a misfolding of the sequence
with a concomitant reduction in activity (7). Since this
discovery nearly all of our subsequent designs have focused
on the NK4- peptides where the lysines are mobile and do not
interact with the TM segment.
A series of NK4-M2GlyR peptides were subsequently
synthesized with deletions at the nonadducted terminus.
Truncated NK4-M2GlyR peptides consisting of 22–26 amino
acids (i.e., 1–5 amino acids absent from the C-terminus)
yielded fully active peptide assemblies (8). In the process
of truncating the NK4-adducted native sequence, a number
of hydrophilic residues were omitted as deﬁned by theWimley
and White hydrophobicity scales developed for transmem-
brane sequences (9–12). The increase in hydrophobicity is
reﬂected in the reduced solubility of the deletion peptides.
Among the residues removed was Arg-22 in the C-terminus of
the parent M2 sequence. It has been postulated, based on
solution NMR studies in dodecyl phosphatidyl choline
micelles, that the registry of the wild-type transmembrane
segment is deﬁned by residues Arg-3 and Arg-22, thereby
deﬁning an 18-residue TM segment (13,14). Examining the
crystal structures of membrane proteins, arginine is often
located at the water/lipid interface in TM segments (15–17).
Without the C-terminal arginine in theM2GlyR-p22 sequence,
both ion selectivity and positioning or registry of the TM
segmentwithin the acyl lipid core are potentially compromised.
Therefore, this study was initiated to evaluate the effects on
channel transport properties of reintroducing an arginine at
positions near the new carboxyl-terminus. Arginine residues
were introduced individually at positions 18–22 and assayed
for induced anion transport across MDCK monolayers. In the
second and third sets of experiments double amino acid re-
placementswere generatedwith aromatic amino acids placed at
or near the C-terminus alongwith arginines at positions 19–22.
In addition to the arginine replacements other aromatic
amino acids (tyrosine, tryptophan, and phenylalanine) were
placed at or adjacent to the C-terminus. Aromatic residues have
been observed in numerous TM segments at the aqueous/lipid
interface (18–21). In a recently published study (22), we
observed that substituting Ser-22 in NK4-M2GlyR-p22 with
tryptophan, was associated with decreased self-association in
solution. Multidimensional proton NMR studies revealed that
the tryptophan alters the solution structure of the peptide such
that a new fold containing a hydrophobic cleft is generated.
Based on CD studies, upon binding to membranes the
tryptophan-containing peptide spontaneously refolds, adopting
a more helical secondary structure.
The tryptophan substituted NK4-M2GlyR-p22, S22W,
showed several differences with regard to the maximal short
circuit current (IscMAX) and the concentration dependence
for one-half maximal short circuit current (K1/2). Comparing
the full-length NK4-M2GlyR-p27, with the truncated NK4-
M2GlyR-p22 and the substituted NK4-M2GlyR-p22 S22W,
IscMAX values of 26.26 5.7, 23.76 5.6, and 13.06 1.0 mA
cm2 were measured, respectively. In contrast, the con-
centrations for K1/2 were 271 6 71, 210 6 70, and 44 6 5.9
mM, respectively. The substituted NK4-M2GlyR-p22 S22W
sequence was able to assemble more easily, however, there
appears to be a cost with regard to the maximum permeation
rate.
In this report, biochemical and electrophysiological results
demonstrate that the NK4-M2GlyR-p22 sequence can be
modiﬁed to bring about a variety of new bio-based channels
with improved rates of supramolecular assembly with a large
ensemble of conductances. In the companion paper, three of
these substituted sequences were modeled in different hydro-
phobic environments.
EXPERIMENTAL SECTION
Peptide synthesis
All peptides were synthesized using solid phase methods employing the
9-ﬂuorenylmethoxycarbonyl (Fmoc) amino protection strategy, as described
previously (16). All peptides were puriﬁed by reversed-phase HPLC and
characterized by both matrix assisted-laser desorption time-of-ﬂight mass
spectroscopy (MALDI-TOF) and ESI ion-trap mass spectroscopy.
Solubility studies
The solubility of the different peptides was determined using a previously
published method (20). Brieﬂy, saturated solutions of the crude peptides in a
modiﬁed Ringer solution ‘‘A’’ (pH 7.4: mOsm 305; 2.5 mM K2HPO4; 2.0
mM CaCl2; 1.2 mM MgSO4; 5 mM glucose; 5.0 mM Na-acetate; 6 mM
L-alanine; 1.0 mM Na3-citrate; 115 mM NaCl; 4.0 mM Na-lactate; 0.5 mM
n-butyric acid; 20 mM NaHCO3; 14.1 mM rafﬁnose) were prepared by
dissolving increasing amounts of peptide directly in 0.1 ml of the above
solution until no more went into solution. Samples were centrifuged for
3 min at 15,000 3 g, and the supernatant was analyzed for protein concen-
tration with the BCA protein assay (Pierce Chemical, Rockford, IL). Bovine
serum albumin served as the protein standard and all peptide samples
were corrected for dye binding differences that have been determined
previously (4).
Cell culture
MDCK cells were a generous gift of Dr. Lawrence Sullivan (KUMC, Kansas
City, KS) and were cultured as described previously (3). The HT-29 colon
cancer parental cell line (ATCC No. HTB-38) was cultured in McCoy’s 5a
medium with 1.5 mM L-glutamine, 2.2 g/L sodium bicarbonate, 10% fetal
bovine serum, in a humidiﬁed atmosphere of 95% air: 5% CO2. Cells were
plated at low density 12–18 h before electrophysiology experiments on
sterile glass coverslips, which formed the bottom of the experimental
chambers.
Chemicals
1-EBIO (Acros Organics, Division of Fischer Scientiﬁc, Pittsburgh PA)
was prepared as a 1-M stock solution in dimethyl sulfoxide (DMSO)
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(23,24). All other chemicals were purchased from Sigma-Aldrich Chemical
(St. Louis, MO) and were of reagent grade unless otherwise noted.
Transepithelial ion transport measurements
Transepithelial ion transport was evaluated in a modiﬁed Ussing chamber
(Model DCV9, Navicyte, San Diego, CA). For electrical measurements,
MDCK cells were bathed in a modiﬁed Ringer solution ‘‘B’’ (120 mM
NaCl, 25 mM NaHCO3, 3.3 mM KH2PO4, 0.8 mM K2HPO4, 1.2 mM
MgCl2, and 1.2 mM CaCl2 prepared fresh daily) (3) maintained at 37C, and
continuously bubbled with 5% CO2/ 95% O2 to provide aeration and mix the
ﬂuid in the chambers. The transepithelial membrane potential (VTE) was
clamped to zero and the Isc was measured continuously with a voltage clamp
apparatus (Model 558C, University of Iowa, Department of Bioengineering,
Iowa City, IA). Data acquisition was performed at 1 Hz with a Macintosh
computer (Apple Computer, Cuppertino, CA) using Aqknowledge software
(version 3.2.6, BIOPAC Systems, Santa Barbara, CA) with an MP100A-CE
interface. Isc data are presented in tabular or bar chart forms at steady-state
ﬂux levels.
Ion transport data analysis
The data points represent the mean Isc stimulated by the peptide at
concentrations between 10 and 500 mM and the error bars show the standard
error of the mean. The differences between control and treatment data were
analyzed using ANOVA and Student’s t-test. The probability of making a
type I error ,0.05 was considered statistically signiﬁcant. The lines are a
best ﬁt of a modiﬁed Hill equation to the data, Isc ¼ IMAX3ðxn=ðKn1=21xnÞ;
where K1/2 is the concentration of peptide that provides a half-maximal Isc
and n represents the Hill coefﬁcient.
Planar lipid bilayer experiments
Peptide ion channel activity was measured by planar lipid bilayer
experiments. From supplied solutions (10 mg/mL in chloroform) of POPC
(1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine) and POPG (1-palmito-
yl-2-oleoyl-sn-glycero-3-phospho-rac-(1-glycerol)) (Avanti Polar-Lipids,
Alabaster, AL), a 70:30 molar ratio of POPC/POPG was prepared in chlo-
roform. The lipid chloroform solution was evaporated under a stream of
nitrogen and the lipids resuspended in 100 mL n-decane (Sigma) to a total
lipid concentration of 10.0 mg/mL. Lipid bilayers composed of (70:30 mol
ratio) were formed across a 150-mm aperture in the wall of a Delrin cup. The
grounded electrode was applied to the trans side of the bilayer chamber with
the voltage electrode applied to the cis side. Both the cis and trans chambers
contained 0.1 M KCl connected by 1.0 M KCl agar bridges to the electrodes
submerged in 2.0 M KCl. Lipids and peptide stock solutions were applied to
the cis side of the bilayer apparatus. Bilayer current recordings were made
with an EPC 9 patch clamp (HEKA; Lambert, Germany) and a Gould
OS4100 digital storage oscilloscope (Cleveland, OH). The bilayer was
conditioned and tested for stability and consistency before addition of
peptide stock. Peptide was added by increments until sustained channel
activity was observed.
Whole-cell patch-clamp analysis
The electrophysiology experiments were performed using standard high
sodium, low potassium extracellular buffered saline solution and a high
potassium buffered saline solution intracellularly. Intracellular calcium was
maintained at 100 nM using EGTA and calcium saturated EGTA (25). The
standard bath solution contained (in mM) 140 NaCl, 4.7 KCl, 1 CaCl2, 1.1
MgCl2, 10 HEPES (pH 7.4), and 10 glucose. In the ion-substituted buffers,
K HEPES and NMDG HEPES, the NaCl was replaced by 140 KCl or 140
NMDG Cl, respectively. Pipette solution contained 20 NaCl, 40 KCl, 80 K
glutamate, 104 CaCl2, 1.1 MgCl2, 10 HEPES (pH 7.4), and 10 glucose.
Recording electrodes were pulled from borosilicate glass and ﬁre polished
to a resistance of 2–5 V when ﬁlled with the standard pipette solution.
Whole cell currents were measured and recorded using a HEKA EPC 10
ampliﬁer with Pulse software (version 8.76, HEKA Instruments, Southboro,
MA). All recordings were obtained at 37C by a water-jacketed perfusion
system. Peptides were added to the experimental chamber by appropriate
dilution with the ﬂow stopped for 45–60 s, and then ﬂow was resumed.
Whole-cell patched HT-29 cells were sequentially superfused with 140
mM NaCl HEPES, KCl HEPES, and NMDG Cl HEPES buffered saline.
Pipette chloride was 60 mM, potassium 140 mM. Resting membrane
potential (Vmem) varied between35 and55 mV (n¼ 15). Following bath
exchange of NaCl for KCl, Vmem depolarized to 0 mV, subsequent cellular
superfusion with NMDG Cl resulted in Vmem hyperpolarizing back to near
initial conditions (25–45 mV, n ¼ 12). Thus, under control conditions the
membrane was selectively permeable to potassium.sodium, as predicted
from previous studies. The channel-forming peptides were added directly
to the bath solution once control whole-cell currents were established, and
current-voltage relationships were monitored.
Chemical cross-linking reaction for M2GlyR
related sequences
Bis-[sulfosuccinimidyl] suberate (BS3) was purchased from Pierce. Precast
1.0 mm, 10 well, 10–20% tricine gels, tricine SDS buffer kit, Mark 12TM
unstained standard, and SilverXpress silver staining kit were obtained from
Invitrogen (Carlsbad, CA) and used as described previously (8). Cross-
linking was performed using a 40-fold molar excess of BS3 in Ringer
Solution ‘‘B’’, as described previously (8,22).
Circular dichroism studies
Circular dichroism (CD) spectra were recorded in SDS micelles to monitor
structural differences in secondary structure between the different NK4-
M2GlyR-p22 substituted sequences at 25C in deionized, doubly distilled
H2O containing SDS micelles and 10 mM NaCl and 10 mM phosphate
buffer pH 7.0 (Ultrapure grade from Sigma-Aldrich). Spectra were recorded
on a Jasco J-720 spectropolarimeter with Neslab RTE-111M circulator using
a cylindrical, water-jacketed, quartz cuvette with a 1.0-mm pathlength.
Spectra shown are an average of eight scans recorded at a rate of 20 nm/min
with a 1.0-nm step interval. Peptide concentrations of between 50 and 300
mM were used for the sequences in Tables 1–3. These concentrations cover
the range over which biological activity is observed. Detergent monomer/
peptide molar ratios of .200:1 were maintained. Peptide concentrations
were determined with the Pierce BCA microprotein assay using a calibrated
M2GlyR peptide solution as the standard (4). The concentration of the stock
solution of NK4-M2GlyR was determined using mol-percent ratios of the
hydrolyzed PTC-amino acids by amino acid analysis. Data were analyzed
using software provided by the manufacturer.
RESULTS AND DISCUSSION
Structure, activity, and solution association
studies with M2GlyR derived peptides containing
arginine at or near the C-terminus
In the native M2GlyR sequence an arginine residue is located
near the C-terminus of the pore-forming TM segment. This
residue was deleted when the peptide was truncated to 22
residues in length (8). Restoration of a positive charge near the
C-terminus of the 22-residue peptide was tested with regard to
increasing transport rates. A helical wheel projection of the
M2GlyR-p22 helix reveals an even distribution of the polar
2140 Shank et al.
Biophysical Journal 90(6) 2138–2150
residues. Not knowingwhere to optimally substitute an arginine,
a series of M2GlyR peptides was prepared with arginine re-
placing one amino acid in each of the ﬁve C-terminal sequence
positions. These sequences are shown in Table 1 with their
respective masses, solubility, and macroscopic kinetic constants
that describe the relationships between apical peptide concen-
tration and net ion transport rates across epithelial monolayers
(Hill coefﬁcient (n), IscMAX, and K1/2). Sequence 1 is the
unmodiﬁed NK4-M2GlyR-p22 sequence, which displays nearly
identical values for the Hill coefﬁcient (n), IscMAX, and K1/2
values, as does the full-length NK4-M2GlyR-p27 (22). In
sequences 2–6, the stepwise repositioning of the substituted
arginine is shown. Substitution of the arginine at any of the
shown positions raised aqueous solubility as expected, given the
more hydrophilic nature of the arginine relative to that of the
replaced amino acids. The greatest increase in solubility was ob-
served when the hydrophobic residue methionine was replaced
by arginine (sequence 6, Table 1).
The solution association properties of sequences 1–6 were
examined using an amino-reactive bifunctional cross-linking
reagent. These studies were undertaken to assess whether the
introduction of an arginine at or near the C-terminus would
also reduce solution associations. Peptide cross-linking stud-
ies using BS3 revealed the presence of numerous water-
soluble associations as assessed by silver stained polyacryl-
amide gel electrophoresis (similar to that shown in Fig. 5 in
Broughman et al. (8)). A ladder of peptide associations was
seen in the presence of the primary amine cross-linking agent.
Monomer accounts for about half of the material observed in
the individual gel lanes. In the absence of the cross-linker,
SDS-containing loading buffer alone reduced the solution
associations to the monomeric form. Clearly the introduction
of an arginine anywhere within the ﬁve C-terminal residues
has no effect on the intrinsic solution association properties of
the nonsubstituted sequence (sequence 1). The soluble, yet
highly associated, forms of the peptide are believed to be
biologically inert, which impacts the concentration of bioac-
tive material. The hydrophobic faces of the peptides are
presumed to drive these associations (22). BS3 has proven
effective in trapping the associated forms of the lysine ad-
ducted channel-forming peptides (8,22). We see no evidence
of recruitment of peptides to generate higher aggregates that
are captured by a free half of the bifunctional cross-linker,
as detected by mass spectrometry and SDS-PAGE analyses
using either our sequences or melittin in concentration and
time-dependence studies.
The secondary structures for sequences 1–6 were analyzed
by CD in SDS micelles (20 mM) in the presence of 10 mM
NaCl and 10 mM phosphate buffer pH 7.0. Under these
conditions the SDS has a critical micellar concentration of
4.4 6 0.3 mM as measured by isothermal calorimetry. The
CD experiments for all sequences in this study were carried
out in SDS micelles because they induce the greatest helicity
for the different modiﬁed NK4-M2GlyR sequences when
delivered from solution. In numerous structural studies, both
NMR and CD, TFE and SDS micelles have been employed
to mimic membrane environments (26–30). CD experiments
were also conducted in extruded phospholipid micelles
(POPC/POPS; 70:30), where peptide was delivered from
solution. Under these conditions only beta-structure was
observed. Some helical structures were obtained when the
peptides were dried in the presence of the phospholipids
before hydration and extrusion, but nothing approaching the
values published in NMR structural studies on members of
the cys-loop channel superfamily: glycine receptor (13,14)
and nicotinic acetyl choline receptor (31). It appears that
micelles prepared using two different phospholipids are not
goodmodels for the apical membrane of epithelium.Magzoub
et al. (32) published a revealing report showing the variability
in the secondary structure of the membrane active peptide
‘‘penetratin’’ (pAntp) in phospholipid liposomes (SUVs). The
authors observed different peptide secondary structures (ran-
dom coil, b, and helical) by varying the ratio of the different
phospholipids (i.e., POPC/POPG) and peptide/lipid ratios.
Spectra were recorded for each sequence at 30–50 mM
(Fig. 1) and 300 mM (not shown). Identical overlapping
spectra were obtained for the individual sequences at all
peptide concentrations and similar spectra were obtained for
all substituted sequences. Peptide sequences 1–5 possessed
some helical content, showing minima at 208 and 222 nm.
The helical content for these sequences, as measured by CD,
was consistent with that indicated by previous multidimen-
sional NMR structural studies recorded with the native GlyR
TM2 peptide dissolved in DPC micelles (13). Sequence 6
had minima that were slightly blue-shifted, 204 and 219 nm.
This peptide showed no channel-forming activity (discussed
TABLE 1 Characterization of M2GlyR-p22 derived peptides with C-terminal arginines
Sequence Replacement Mr (Da) Sol.(mM) n IscMAX (mA/cm
2) K1/2 (mM)
1. KKKKPARVGLGITTVLTMTTQS none 2358.9 11.1 1.9 6 0.6 23.7 6 5.6 210 6 70
2. KKKKPARVGLGITTVLTMTTQR S22R 2427.9 15.6 2.7 6 0.9 24.1 6 5.3 290 6 60
3. KKKKPARVGLGITTVLTMTTRS Q21R 2387.0 19.7 2.2 6 1.1 31.0 6 18.0 390 6 220
4. KKKKPARVGLGITTVLTMTRQS T20R 2414.0 18.7 1.3 6 0.5 28.5 6 14.8 310 6 227
5. KKKKPARVGLGITTVLTMRTQS T19R 2414.0 18.3 0.7 6 0.6 16.3 6 3.5 120 6 40
6. KKKKPARVGLGITTVLTRTTQS M18R 2383.9 23.3 0.6 6 2.6 3.0 6 4.0 840 6 200
Sequences and physical and electrophysiological properties are shown. Bolded arginine residues deﬁne the putative TM segment. IscMAX is maximal
anion ﬂux and K1/2 is the concentration required to obtain one-half of the maximal anion ﬂux calculated based on the Hill equation using the data presented in
Fig. 2.
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below). We speculate that the observed shift in the CD
minima reﬂects an altered structure induced by a less fa-
vorable peptide/detergent micellar interaction.
The ability to induce anion secretion across epithelial mono-
layers was tested for sequences 1–6 (Table 1). Polarized epi-
thelial cells (MDCK monolayers) were exposed to increasing
concentrations of peptide sequences 1–6 in the presence of
1-EBIO (8,23,24) (Fig. 2). Table 1 also presents the summa-
rized ion transport constants obtained for sequences 1–6
shown in Fig. 2. Introduction of an arginine residue to the
NK4-M2GlyR-p22 sequence in any one of the four C-terminal
amino acid sites (sequences 2–5; Table 1) causes only subtle
changes in maximal net ionic ﬂux (Isc) or concentration
dependence (K1/2) relative to that seen for the wild-type
sequence (sequence 1; Table 1). The calculated K1/2 value is
an indicator of the peptide afﬁnity for supramolecular
assembly. Addition of the Met-18Arg substituted peptide
(sequence 6; Table 1) showed no increase in transport rates
over pretreated values. Clearly replacing the hydrophobic
methionine with a hydrophilic arginine was not well tolerated.
Because the secondary structure (Fig. 1) for this sequence did
not signiﬁcantly differ from that of the active sequence 3, the
defect in sequence six must lie in its inability to interact with
the membrane or adversely effect supramolecular assembly.
Based on earlier studies (13–21,33) that describe the
interfacial role of charged amino acids in TM segments, the
endogenous arginine at position 7 and the newly introduced
arginine in these substituted sequences are presumed to
reside at the lipid/water interfaces. Evidence indicating that
the role of the two arginines in deﬁning the lipid/water
interfaces is supported by the recently deﬁned hydrophobic
core spanning sequence of M2GlyR, based on NMR studies
conducted in DPC micelles (13). This 18-residue segment is
shown (underlined) within the wild-type TM2 sequence
(PARVGLGITTVLTMTTQSSGS RA). In cases with the
NK4-M2GlyR-p22 substituted sequences, the absence of
three of the predicted lipid spanning residues (boxed),
present in the wild-type sequence, suggests that a different
grouping of amino acids must span the membrane core. A
core-spanning segment of 15 residues has been reported by
others and is sufﬁcient to produce a strong blue shift for an
internal tryptophan (34). In this same study, an 11-residue
peptide core was also able to span a detergent micelle that
had lipid acyl chains made up of 16 carbon atoms.
Based on preliminary NMR and computer modeling
studies of NK4-M2GlyR-p22, it appears that the one or
more of the N-terminal lysyl residues deﬁne the extracellular
interfacial boundary. At the C-terminus, arginines substituted
at positions 19–22 will position their guanido group at the
lipid/water interface. Arginine at position 18 cannot. To
maintain an 18-residue membrane spanning length, as the
C-terminal arginine is positioned at residue 19, 20, 21, or 22,
Arg-7must be translocated partway down into the TMportion
of the sequence and different lipid core embedded segments
are deﬁned by different N-terminal lysine anchors.
The inactivity of the Met-18 substitution is most likely
due to lack of membrane insertion due to an energetically
unfavorable positioning of the arginine within the acyl core
of the bilayer or by requiring too many lysines to be accom-
modated within the lipid acyl core. Charged amino acid
FIGURE 1 CD spectra of the arginine substituted NK4-M2GlyR-p22. CD
spectra of NK4-M2GlyR wild type (sequence 1, Table 1) and arginine
substituted sequences (sequences 2–6, Table 1) were recorded using 50 mM
peptide in 10 mM sodium dodecylsulfate containing 10 mM NaCl and 10
mM phosphate buffer, pH 7.0, at room temperature (27–29C). CD spectra
for all peptides (sequences 1–6) are an average of eight data sets collected
for each peptide. NK4-M2GlyR-derived peptides spectra are as follows:
sequence 1 (s), sequence 2 (¤), sequence 3 (d), sequence 4 (:), sequence
5 (;), and sequence 6 (n).
FIGURE 2 Concentration-dependence of Isc induced by NK4-M2GlyR-
p22 derived peptides with arginine replacement on MDCK epithelial mono-
layers. Symbols represent the mean and standard error of three to seven
observations for each concentration tested. Solid lines represent the best ﬁt
of a modiﬁed Hill equation to each data set. The NK4-M2GlyR derived
peptides concentration dependent ISC curves are as follows: sequence 1 (s),
sequence 2 (¤), sequence 3 (d), sequence 4 (:), sequence 5 (;), and
sequence 6 (n).
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residues are commonly found within transmembrane domains
of transporters where they usually form a salt bridge with a
residue of opposite charge (35–42). No such charge neutral-
ization is possible in the homooligomer assembly. Snorkeling
of the arginine and lysine side chains is restricted to sequence
positions that are near the water lipid interface (43–45).
Based on the arginine substitution data forNK4-M2GlyR-p22
series shown in Table 1, an arginine can be accommodated in
any of the four C-terminal sites. Reintroduction of an arginine
into those positions does not signiﬁcantly alter the ion transport
properties of the sequence in cultured epithelial cells. Although
the arginine-substituted sequences have higher solubility, this
property is not reﬂected in decreased solution associations of
the peptides. If lipid core embedded sequence length is re-
stricted to 18 residues, we postulate that as the position of ex-
isting or potential interfacial residues are relocated, altered
assembly architectureswith different helix anchors, helix pitch,
helix angles, and different pore-lining residues must occur to
maintain the transmembrane orientation. The apparent plastic-
ity of the TM segment in altering its structure to maintain its
perpendicular orientation can explain altered transport function
in the NK4-M2GlyR-p22 substituted homooligomeric assem-
blies.
Structure, activity, and solution association
studies with M2GlyR derived peptides
containing tryptophan with arginine residues
at or near the C-terminus
Tryptophan was introduced into the NK4-M2GlyR-p22
sequence to replace the C-terminal serine (sequence 7 in
Table 2). This sequence, previously described in Cook et al.
(22), was predominantly monomeric in solution and assem-
bled into anion permselective channels at lower concen-
trations compared to the truncated wild-type peptide
(sequence 1). However, the sequence attained only ;55%
of the maximal anion current seen in the wild-type sequence.
A new series of double replacement peptides was prepared
with tryptophan and arginine at selected locations within the
last four positions in the C-terminus (Table 2). Arginine was
substituted at Q21 (sequence 8), T20 (sequence 9), and T19
(sequence 10) while holding tryptophan at position 22.
Sequence 11 was designed to test whether moving the
arginine outside the membrane would produce a more stable
channel based on thermodynamic considerations.
CD spectra for the tryptophan containing peptides at 50
mM and 300 mM were measured in 20 mM SDS in the
presence of 10 mM NaCl and 10 mM phosphate buffer, pH
7.0 (not shown). No detectable changes in the CD spectra
were recorded at either concentration. All peptides retained
their overall helical secondary structure. None of the se-
quences possess .40% a-helical content in SDS, which is
consistent with the previously discussed report showing the
NMR structure of the M2GlyR segment recorded in SDS
micelles (15). Structure was conﬁned to only the transmem-
brane segment; residues outside of this hydrophobic envi-
ronment were highly mobile, with no apparent stable
structure (13,14). Within the lipid embedded segment,
preliminary solution NMR results in both 40% TFE and
SDS micelles suggest that the structured segment is bent and
that only a portion of the segment is in a true a-helical
conformation (13,14).
Fig. 3 shows the concentration dependence of the maximal
ion transport rate for sequences 7–11 (Table 2). Table 2
presents the summarized ion transport kinetic constants from
Fig. 3. The solid lines in the ﬁgure represent the best ﬁt of a
modiﬁed Hill equation to each data set. Sequence 1 displayed
a concentration-dependent response similar to that observed
with the 27-residue full-length CK4-M2GlyR and NK4-
M2GlyR peptides (5,6). Sequence 1 provides benchmark
values of IscMAX of 23.7 6 5.6 mA/cm
2, K1/2 of 210 6 70
mM, and Hill coefﬁcient of 1.9 6 0.6.
Introduction of a tryptophan in the presence and absence
of the added arginine (sequences 7–11, Table 2) had a dra-
matic effect on the concentration required for half-maximal
ion transport activity. The left-shifted K1/2 values ranged
from 36 to 87 mM as compared with the 210 mM observed
for the unmodiﬁed sequence 1. The four doubly substituted
sequences (sequences 8–11, Table 2) exhibited similar left
shifts in the K1/2 for maximal anion transport as that
measured for sequence 7, with a sole tryptophan substituted
in position 22 (Table 2) and as recently reported (23). These
sequences with left-shifted K1/2 values form homooligomeric
supramolecular assemblies at lower concentrations.
With regard to IscMAX, the doubly substituted sequences
had increased maximal transport rates relative to either the
TABLE 2 Characterization of M2 derived peptides with tryptophan and arginine substitutions
Sequence Replacement Mr (Da) Sol.(mM) n IscMAX (mA cm
2) K1/2 (mM)
1. KKKKPARVGLGITTVLTMTTQS none 2358.9 11.1 1.9 6 0.6 23.7 6 5.6 210 6 70
7. KKKKPARVGLGITTVLTMTTQW S22W 2458.0 1.9 5.4 6 2.9 13.0 6 1.0 45 6 6
8. KKKKPARVGLGITTVLTMTTRW Q21R, S22W 2486.1 4.9 3.3 6 1.6 26.5 6 3.2 36 6 5
9. KKKKPARVGLGITTVLTMTRQW T20R, S22W 2513.1 5.2 2.3 6 0.8 22.7 6 2.7 87 6 15
10. KKKKPARVGLGITTVLTMRTQW T19R, S22W 2513.1 5.1 3.5 6 0.7 33.7 6 1.3 71 6 5
11. KKKKPARVGLGITTVLTMTTWR Q21W, S22R 2486.0 22.0 3.8 6 2.2 33.6 6 2.2 55 6 6
Sequences and physical and electrophysiological properties are shown. IscMAX is maximal anion ﬂux and K1/2 is the concentration required to obtain one-half
of the maximal anion ﬂux and are calculated based on the Hill equation using the data presented in Fig. 3.
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wild-type (sequence 1) or C-terminal tryptophan substituted
(sequence 7) peptides. In the doubly substituted sequences
the position of the arginine relative to the tryptophan also had
an effect on IscMAX. In sequences 8 and 9 introduction of
arginine at positions 20 or 21 was associated with a greater
IscMAX (22.7 6 2.7 and 26.5 6 3.2 mA/cm
2, respectively)
over that seen with the tryptophan alone substituted se-
quence. These IscMAX values are similar to that seen for
the wild-type M2GlyR-p22 (sequence 1). Introduction of the
arginine at position 19 (sequence 10) and inverting the
arginine-tryptophan pair of sequence 8 to tryptophan-
arginine (sequence 11) resulted in even larger IscMAX
values of 33.7 6 1.3 and 33.6 6 2.2 mA/cm2, respectively.
Most importantly, sequences 8–11 showed greatly enhanced
efﬁcacy with Isc values equaling IscMAX for sequence 1 with
concentrations at or below 50 mM. The sum effect of
changes in the kinetic parameters (IscMAX and K1/2) is a
substantial reduction in the peptide concentration required to
attain anion secretion rates that will likely be relevant in
future basic research and applied applications. Sequences 7,
8, 10, and 11 have greater Hill coefﬁcients (5.46 2.9, 3.36
1.6, 3.5 6 0.7, and 3.8 6 2.2, respectively) than that
calculated (1.9 6 0.6) for sequence 1. Sequence 9 has a Hill
coefﬁcient (2.3 6 0.8) similar to that seen with sequence 1.
The increase in the Hill coefﬁcients to values approaching
ﬁve suggests that association/dissociation mechanisms in the
bilayer are sensitive to structural changes in the peptide and
consistent with the prediction that the channel pore is a homo-
oligomeric supramolecular assembly.
Two processes are postulated to account for the decrease
in the concentration required for half-maximal activity
(K1/2). Firstly, the presence of a tryptophan residue elimi-
nates the formation of higher molecular weight associations
in aqueous environments. This effectively increases the
concentration of soluble monomer, proposed to be the most
membrane active species (22). Secondly, the propensity of
tryptophan to reside at the aqueous/lipid interface (18–21)
could set the registry of the transmembrane segment that
spans the bilayer. In the absence of an arginine or aromatic
residue at or near the C-terminus the peptide could rise up
and down within the ﬂuid bilayer thereby affecting the depth
of peptide insertion into the membrane and tilt angle of the
peptide. By providing a membrane anchor at position 22, a
reduction in the degrees of freedom for the transmembrane
registry of the peptide would occur thereby facilitating as-
sembly at lower concentrations.
As assessed in the Ussing chamber experiments, reintro-
duction of an arginine near the C-terminus contributes a third
factor that inﬂuences the minimum concentrations required
for assembly. Introduction of an arginine, at any of the tested
positions, slightly decreases the Hill coefﬁcient, suggesting that
there is an energetic cost in forcing the arginines (transiently)
across the acyl core of the phospholipids. Placing the
arginines at either position 19 or just outside the membrane
appears to be optimal with regard to IscMAX. Placing the
arginine at position 21 appears to be optimal with regard to
K1/2. Placing the arginine at position 20 seems to be the least
optimal position since the Hill coefﬁcient, K1/2 and IscMAX
show the lowest values within this peptide series. Prelimi-
nary computer modeling studies indicate that the arginine in
any of the internal C-terminal positions could snorkel back
toward the membrane to form a second membrane anchor.
There is no evidence that any of the substituted arginines, in
sequences 8–11, are positioned with the side chain pointed
into the water-ﬁlled lumen of the assembled pore.
Single channel recordings obtained in phospholipid
bilayers for sequences 7–11 are shown in Fig. 4. Although
all sequences form de novo channels, the single channel
properties such as conductance, open probability, and open
times are different for each of the sequences. All of the amino
acid substituted sequences described in this report are able to
self-assemble in phospholipid bilayers and provide new
conductance pathways, which can account for the peptide-
induced transepithelial ion transport in intact epithelium.
These results are consistent with those obtained for the
longer CK4-M2GlyR-p27 (5) and NK4-M2GlyR-p27 (6).
Structure, activity, and solution association
studies with M2GlyR derived peptides containing
phenylalanine or tyrosine with arginine residues
at or near the C-terminus
To better understand the role of indole-containing peptides
in lowering K1/2 values, new sequences were prepared that
replaced the tryptophan with either phenylalanine or tyrosine
FIGURE 3 Concentration-dependence of Isc induced by NK4-M2GlyR-
p22 derived peptides with tryptophan and arginine amino acid substitutions
on MDCK epithelial monolayers. Symbols represent the mean and standard
error of six or greater observations for each concentration tested. Solid lines
represent the best ﬁt of a modiﬁed Hill equation to each data set. The NK4-
M2GlyR derived peptides dose dependent Isc curves are as follows:
sequence 1 (s), sequence 7 (h), sequence 8 (n), sequence 9 (3), sequence
10 (,), and sequence 11 ()).
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(sequences 12–16, Table 3). These substitutions were pre-
pared to assess whether any aromatic amino acid (Phe, Tyr,
or Trp) at the C-terminus: 1), increases monomer concen-
trations, 2), alters secondary structure, or 3), sets the registry
of the peptide within the bilayer.
The phenylalanine or tyrosine substituted sequences,
which also contain a second arginine substitution (sequences
12–16, Table 3), displayed increased solubility compared to
their tryptophan containing counterparts with the exception
of sequence 14, the phenylalanine-containing counterpart of
sequence 11. These two sequences had the same solubility
(21 vs. 22 mM). All of the aromatic containing sequences
had lesser amounts of higher molecular weight associations
in aqueous environments (Fig. 5) compared to the aromatic
free sequence (sequence 1, Wallace et al. (24)). Predomi-
nantly monomer, with some dimer, is present in the cross-
linked aromatic sequences.
Secondary structures in SDS micelles were measured, as
before, for sequences 12–16 (Table 3) at both 50 and 300
mM. The CD scans (not shown) for these sequences were
similar to those seen for the arginine-substituted series
(Fig. 1) and the tryptophan containing sequences. All of the
Table 3 sequences had recorded minima at 208 and 222 nm.
Considering the lack of solution aggregation and similar
CD proﬁles, we conclude that these sequences form a similar
hydrophobic fold (in solution) that prevents higher asso-
ciations, similar to that observed by Cook et al. (22) for
sequence 7. Besides improving the concentration of mono-
mer in aqueous solutions, inclusion of any C-terminal aromatic
residue provides a lipid/water interfacial anchor. In addition
to tryptophan, phenylalanine residues are commonly found
(and tyrosine to a lesser extent) at the hydrophobic/hydro-
philic interface for transmembrane segments of membrane
proteins (3–6).
FIGURE 4 Single-channel recordings of
tryptophan and arginine substituted NK4-
M2GlyR peptides in synthetic bilayers.
Channel recordings were made in symmet-
rical 100 mM KCl at 80 mV with a peptide
concentration of 1.0 mM at room temper-
ature for all sequences with the exception
of sequence 8, which was recorded at 80
mV. The bilayer composition was 70:30
POPC/POPG for all samples.
TABLE 3 Characterization of peptides with phenylalanine/tyrosine and arginine substitutions
Sequence Replacement Mr (Da) Sol.(mM) n IscMAX (mA cm
2) K1/2 (mM)
12. KKKKPARVGLGITTVLTMTTRF Q21R, S22F 2447.1 6.1 3.8 6 2.5 21.3 6 2.5 56 6 8
13. KKKKPARVGLGITTVLTMRTQF T19R, S22F 2474.1 12.2 2.3 6 0.3 38.0 6 2.3 120 6 14
14. KKKKPARVGLGITTVLTMTTFR Q21F, S22R 2447.1 21.0 3.1 6 0.6 31.8 6 3.6 120 6 10
15. KKKKPARVGLGITTVLTMTTRY Q21R, S22Y 2463.1 26.9 2.4 6 0.6 29.4 6 3.1 98 6 14
16. KKKKPARVGLGITTVLTMRTQY T19R, S22Y 2490.1 24.5 2.3 6 0.8 18.3 6 2.9 110 6 23
Sequences and physical and electrophysiological properties are shown. IscMAX is maximal anion ﬂux and K1/2 is the concentration required to obtain one-half
of the maximal anion ﬂux and are calculated based on the Hill equation using the data presented in Fig. 6.
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The Isc versus concentration data for sequences 12–16 are
shown in Fig. 6, with the n, IscMAX and K1/2 values
summarized in Table 3. The data for sequences 1 and 11
are included in the ﬁgure for reference. Comparing the
phenylalanine variants (sequences 12–14) to the paired
tryptophan containing sequences 8, 10, and 11, the phenyl-
alanine-containing peptides displayed similar IscMAX but
right-shifted K1/2 values. The tyrosine variants (sequences 14
and 15) of sequences 8 and 10 gave mixed results relative to
their tryptophan counterparts. Sequence 15 showed a higher
IscMAX but right-shifted K1/2 value whereas sequence 16 was
inferior in both respects. With the exception of sequence 12,
the K1/2 values for the tyrosine and phenylalanine containing
peptides are right-shifted relative to the tryptophan contain-
ing peptides but left-shifted relative to the unmodiﬁed
M2GlyR-p22 (sequence 1).
Comparing all of the summarized data in Tables 2 and 3
and the proﬁles shown in Figs. 3 and 6, the sequences dis-
playing the highest ion transport activity and the second and
third most-left-shifted K1/2 values are both tryptophan-
containing peptide sequences (sequences 10 and 11). Based
on the concentrations required for K1/2, a rank ordering of the
assembly promoting effects of the C-terminal aromatic
substitutions are as follows Trp . Phe  Tyr.
Increased anion secretion necessarily reﬂects changes in
underlying biophysical parameters of the epithelial system.
Equation 1 shows that the net current, I, reﬂects the product
of the unitary current (i) (the product of electrical potential,
V, and conductance, g, by Ohms law; Eq. 2), the number of
actively gating channels, N, and the probability of a channel
being in a conducting (i.e., open) state, Po.
I ¼ iNPo; (1)
where,
i ¼ gV: (2)
Channels dissipate electrical gradients regardless of their
conductance or number so long as a portion of the channels
are in a conducting state (i.e., Po. 0). Thus, the elevated net
currents induced by many of the modiﬁed sequences
presented here, cannot reﬂect a channel-induced increase
in the electrochemical driving force, V. Furthermore, the
selected experimental conditions are included to standardize
the net driving force for anion secretion by including 1-EBIO
to maintain an elevated electrochemical driving force. Thus,
differences in maximal current between channel-forming
peptides, as observed in Fig. 3, could reﬂect differences in
unitary conductance, maximal number of active channels,
differences in Po, or some combination of these possibilities.
Because saturation is observed with all peptides tested, one
must conclude that some maximal number of channels is
conducting anions at any point in time. The possibility that
anion loading limits net secretion is ruled out for any
situation in which,;30 mA cm2 is observed. Results from
studies employing sequence 10 (Fig. 3), and previously
reported observations (7,8) demonstrate that MDCK mono-
layers are routinely capable of secreting anions at a rate
.30 mA cm2. Thus, results suggest that either the conduc-
tance, maximal number of channels, or open probability is
reduced for the other sequences shown in Figs. 3 and 6.
A combination of these effects could also account for these
results. Differences in the Hill coefﬁcient might suggest that
alternative numbers of monomers associate in the membrane
to form active channels. Thus, at a saturating peptide con-
centration in the membrane, differing numbers of channels
FIGURE 5 Cross-linking study of arginine and aromatic substituted
peptides in solution. Tricine 10–20% gradient polyacrylamide gel of cross-
linking patterns NK4-M2GlyR-p22 derived peptides with aromatic and
arginine amino acid substitutions (150 mM) treated with a 40-fold excess of
cross-linking reagent in Ringers buffer ‘‘B’’. Peptides treated with BS3 are
labeled according to the sequence numbers given in Tables 2 and 3. The
protein bands are visualized using silver stain.
FIGURE 6 Concentration-dependence of Isc induced by NK4-M2GlyR
p22 derived peptides with either phenylalanine or tyrosine and arginine
amino acid substitutions on MDCK epithelial monolayers. Symbols
represent the mean and standard error of four or greater observations for
each concentration tested. Solid lines represent the best ﬁt of a modiﬁed Hill
equation to each data set. The NK4-M2GlyR derived peptides dose-
dependent ISC curves are as follows: sequence 1 (s), sequence 11 ()),
sequence 12 (*), sequence 13 ( ), sequence 14 (4), sequence 15 ( ) and
sequence 16 ( ).
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may form and channels with different stoichiometries might
exhibit unique conductances and gating kinetics. We are
using analytic ultracentrifugation studies in micelles to verify
the existence of assemblies with different oligomerization
states. Alternatively, one might postulate that associated
forms of some sequences are both conductive and particu-
larly stable resulting in an elevated Po. The unitary
conductance may also differ depending on the sequence
although we view it as unlikely that anion-selective trimers,
tetramers, and pentamers would form. One might hypothe-
size that introduction of the new amino acids at the C-terminus
alter both the sequence of the embedded segment within the
FIGURE 7 Current-voltagerelationships:patched
HT-29 cells (control conditions) were sequen-
tially superfused with 140 mM NaCl (n), KCl
(d), and NMDG Cl (:) HEPES buffered saline
solutions. The pipette holding potential was
increased stepwise from either 50 to 150 mV
in 10 mV steps. Treatment conditions (NK4-
M2GlyR-p27, sequences 1, 7, and 10) Channel-
forming peptides were added directly to the bath
chamber after a whole-cell patch was obtained
(n). Upon formation of stable channels (¤), NaCl
HEPES buffer bathing the cell was exchanged for
KCl buffer (d) followed by NMDG Cl buffer
(:). Representative current overlays for the K
HEPES bath are shown to the right. The pipette
contained K1 and reduced Cl (see Experimental
Section). Whole-cell currents were measured in pA.
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hydrophobic core as well as the pore-lining residues thereby
modulating the throughput of the channel. We are currently
mapping the pore-lining residues in NK4-M2GlyR-p22 S22W,
T19R (sequence 10) using a cysteine scanning approach to
address this alternative hypothesis. These studies are beyond
the scope of this work.
Lastly, an ion selectivity study was performed on the full-
length NK4-M2GlyR-p27 (22) as well as sequences 1, 7, and
10 (Fig. 7 and Table 2) in a whole-cell membrane patch-
voltage clamp experiment using a human colonic carcinoma
cell line (HT-29). These results give an indication of the type
of changes that are induced by the amino acid replacements
discussed in this study. NK4-M2GlyR-p27, sequence 1, and
sequence 10 increased whole-cell conductance two- to
fourfold over baseline and induced a left-shift in the whole-
cell reversal potential in the presence of Na1 or NMDG1 as
the predominant bath cation, suggesting a cation permselec-
tivity sequence of K1Na1.NMDG1. With symmetrical
K1 gradients, reversal potentials were approximately zero for
the untreated cells and for sequence 7. NK4-M2GlyR-p27,
sequence 1, and sequence 10, however, exhibited reversal
potentials that were negative, consistent with substantial Cl
permeability. These data suggest a Cl permselectivity
sequence of NK4-M2GlyR-p27 . sequence 10 ¼ sequence
1. sequence 7, although additional work is required to fully
characterize the biophysical ﬁngerprint of these channel
sequences. The inward rectiﬁcation of sequence 1 in K1 and
NMDG1 baths and time-dependent activation at negative
potentials suggests that additional channels are being recruited
into the membrane (increased N in Eq. 1) or that an alternative
conductance (with increased i) becomes favored in these
conditions. These observations will prove useful in the design
of channels with rectifying characteristics. Nonetheless, the
current experiments identify sequence 10 as a lead compound
for channel replacement therapy studies. This peptide shows
three desirable characteristics: ismonomeric in solution; inserts
in membrane and assembles at low aqueous concentrations;
and exhibits Cl selectivity. The inclusion of the arginine at
residue 19 results in a signiﬁcant increase in transport rateswith
some loss of selectivity. Introduction of a presumed second
anchor appears to alter the overall structure of the assembled
channel. Preliminary NMR structural studies indicate that
adding the arginine at position 19 changes the secondary
structure of the peptide.
SUMMARY
The peptides described in this report represent novel designs
with unique activities. The authors are unaware of anyone
else systematically dissecting a native channel-forming
sequence to study the structural elements that drive assem-
bly, ion selectivity, and conductance. All of the sequences
described herein are water-soluble monomers that, when
exposed to membranes, insert and then undergo supramo-
lecular assembly to form testable bioactive structures. These
derived sequences show a wide range of new properties and
structures that have application as new materials as well as
potential as therapeutic agents.
The results presented in this study reveal important
properties about transmembrane peptides derived from the
GlyR M2 sequence. When applied to symmetrical symmet-
rical bilayers or the apical surface of epithelial monolayers,
the derived sequences insert and then assemble into
homooligomeric helical bundles to give ion transport
activities that can be measured across the treated mem-
brane. The activities observed vary from peptide to
peptide, thereby providing a system by which channel-
forming tendencies can be studied and optimized in a
reductionist manner. The self-assembling GlyR M2 derived
sequences have been shortened and modiﬁed through an
iterative process such that a water-soluble peptide is easily
deliverable to membrane surfaces from aqueous solution
while maintaining channel activity.
Charged amino acids such as arginine, and to a greater
extent aromatic amino acids such as phenylalanine and tryp-
tophan, help to deﬁne the registry of the acyl core embedded
segment. Placing the tryptophan C-terminally to the arginine
can lead to the incorporation of that arginine within the
bilayer with the subsequent snorkeling back of its guanido
group back toward the lipid/water interfacial zone to form a
second anchor and perhaps distort the helix TM orientation.
Peptides of uniform sequence length but with differing acyl
embedded segments would therefore produce channels with
altered channel geometries and pore-lining residues.
Placement of an aromatic residue at the C-terminus
eliminates all of the high molecular weight associations of
the peptide thereby increasing the concentration of the bio-
logically active form. The 22-residue peptide sequences
KKKKPARVGLGITTVLTMRTQW and KKKKPARVGL-
GITTVLTMTTWR reveal themselves as the most potent
channel-forming sequences, showing high levels of ion
transport activity at a peptide concentration of 60 mM and
attaining a maximum anion current of 34 mA cm2 in epi-
thelial monolayers. The sequence, KKKKPARVGLGITT-
VLTMTTQW, reaches maximal activity at;80 mMwith an
improved efﬁcacy as measured by the 6.2-fold decrease in
K1/2 concentration over that of the full-length NK4-M2GlyR-
p27 (22) with retention of anion selectivity. The peptides
displaying the higher currents appear to be nonselective.
Experiments are under way to determine the structure of
these sequences in SDS micelles as well as to introduce amino
acid substitutions in pore-lining residues to improve anion
selectivity for the sequences with higher transport rates.
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